Biolyzr Aps: Financial statements 2022
CVR: 42991910
Source: annual report 2022, Danish Business Authority
18/01/2022 – 31/12/2022
Biolyzr Aps (CVR 42991910) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 13,586 and a net result of DKK 5,552. Equity in the 2022 report amounted to DKK 45,552. The solvency ratio was 47.5%.
- Gross Profit
- DKK 13,586
- Profit/Loss
- DKK 5,552
- Equity
- DKK 45,552
- Total Assets
- DKK 95,841
- Employees
- 0
Official annual report
Keep an eye on Biolyzr Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of August 9, 2022, Marianne Scheel Fjording is registered as director of Biolyzr Aps.
On August 9, 2022, the company changed its name from Michael Fjording Consult ApS to Biolyzr Aps.
As of January 18, 2022, Michael Fjording is registered as director of Biolyzr Aps.
As of January 18, 2022, Michael Fjording is registered as an owner of Biolyzr Aps with an ownership share of 50%.
Biolyzr Aps was founded on January 18, 2022.
About Biolyzr Aps
Biolyzr Aps is a Danish company of the type Anpartsselskab based in Værløse, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Michael Fjording Consult ApS. The management consists of Marianne Scheel Fjording and Michael Fjording. The company is owned by Michael Fjording. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,654,350 and a net result of DKK 1,244,827 compared with DKK 1,796,043 the year before. Equity in the 2025 report amounted to DKK 3,648,695.
